Clinical Trial Update: Application of mRNA Immunotherapy Technology in EB Virus Related Diseases [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial is evaluating an mRNA immunotherapy for Epstein-Barr virus-associated tumors, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epstein-barr Virus-associated Tumors

Drugs mentioned

• mRNA immunotherapy (experimental)

Snippet

Sponsor: Xinqiao Hospital of Chongqing | Conditions: EBV-associated Tumors | EARLY_Phase 1 | Status: NOT_YET_RECRUITING